Robert Ingram - Cree Lead Independent Director

Director

Mr. Robert A. Ingram was Chairman of the Board of the Company. Since January 2007, he was a General Partner in Hatteras Venture Partners, a VC firm that invests in early stage life science companies in the southeast United States, and he has also served as strategic advisor to the chief executive officer of GlaxoSmithKline plc, a publicly traded pharmaceutical research and development company. From 2003 through 2009, he served as Vice Chairman Pharmaceuticals, GlaxoSmithKline. He previously served as Chief Operating Officer and President of Pharmaceutical Operations of GlaxoSmithKline following the December 2000 merger of Glaxo Wellcome plc and SmithKline Beecham plc. Prior to the merger he served as Chief Executive Officer of Glaxo Wellcome plc and as Chairman, President and Chief Executive Officer of Glaxo Wellcome Inc. Mr. Ingram also serves as Chairman of the Board of Directors of BioCryst Pharmaceuticals, Inc. and Novan, Inc., and serves on the Board of Directors of Malin Corporation plc. He also served as Chairman of the Board of Directors of OSI Pharmaceuticals, Inc. from January 2003 until its sale in June 2010, served on the Board of Directors of Elan Corporationrationration, plc from December 2010 until its sale in December 2013 and as its Chairman from January 2011 until December 2013, and served on the Board of Directors of Valeant Pharmaceuticals International, Inc. from September 2010 to May 2017 and as its Chairman from December 2010 to March 2011 and from January 2016 to May 2016. He previously served as a director of Misys plc, Nortel Networks Corporationration, Wachovia Corporationration, Lowe Companies, Inc., Pharmaceutical Product Development, Inc., Allergan, Inc., Edwards Lifesciences Corporation and Regeneron Pharmaceuticals, Inc. until 2005, 2006, 2008, May 2011, December 2011, December 2012, July 2015 and November 2015, respectively. since 2017.
Age 75
Tenure 7 years
Phone919 313-5615
Webwww.cree.com

Cree Management Efficiency

The company has return on total asset (ROA) of (3.63) % which means that it has lost $3.63 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (11.13) %, meaning that it created substantial loss on money invested by shareholders. Cree's management efficiency ratios could be used to measure how well Cree manages its routine affairs as well as how well it operates its assets and liabilities.
The company currently holds 834.8 M in liabilities with Debt to Equity (D/E) ratio of 0.37, which is about average as compared to similar companies. Cree Inc has a current ratio of 4.1, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Cree until it has trouble settling it off, either with new capital or with free cash flow. So, Cree's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Cree Inc sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Cree to invest in growth at high rates of return. When we think about Cree's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

DIRECTOR Age

Carolyn PittmanMinerals Technologies
57
Lynn RothschildEstee Lauder Companies
66
Wan MartelloUber Technologies
63
Frederick DiSantoEastern Co
56
Aerin LauderEstee Lauder Companies
44
Richard BeyerAnalog Devices
66
John SimpsonAwilco Drilling PLC
66
John CarmolaMinerals Technologies
65
David RobinsonEastern Co
70
Alexander WynaendtsUber Technologies
60
Donald WinterMinerals Technologies
72
Rose BravoEstee Lauder Companies
69
Yasir AlRumayyanUber Technologies
50
Adrian PertierraAsure Software
45
David TrujilloUber Technologies
45
John TomsEastern Co
N/A
David LiddyEastern Co
63
Richard ParsonsEstee Lauder Companies
72
Paul FribourgEstee Lauder Companies
66
Kenton SicchitanoAnalog Devices
73
Marc RobinsonMinerals Technologies
59
Cree, Inc. provides lighting-class light emitting diode and semiconductor products for power and radio-frequency applications in the United States, China, Europe, and internationally. The company was founded in 1987 and is headquartered in Durham, North Carolina. Cree operates under Semiconductors classification in the United States and is traded on NASDAQ Exchange. It employs 5130 people. Cree Inc (CREE) is traded on NASDAQ Exchange in USA and employs 5,130 people.

Management Performance

Cree Inc Leadership Team

Elected by the shareholders, the Cree's board of directors comprises two types of representatives: Cree inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Cree. The board's role is to monitor Cree's management team and ensure that shareholders' interests are well served. Cree's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Cree's outside directors are responsible for providing unbiased perspectives on the board's policies.
Alan Ruud, Vice Chairman of Lighting and Director
DuyLoan Le, Director
Robert Ingram, Lead Independent Director
Michael McDevitt, CFO and Executive VP
Robert Tillman, Independent Director
Howard Nye, Independent Director
Claude Demby, Senior Vice President and General Manager, LED Products
Gregg Lowe, President CEO, Director
John Hodge, Director
John Replogle, Director
Clyde Hosein, Independent Director
Franco Plastina, Interim Executive VP Power and Rf and Independent Director
Darren Jackson, Chairman of the Board
Charles Swoboda, Chairman, CEO and Pres
Neill Reynolds, CFO, Executive Vice President
Norbert Hiller, Executive VP of Lighting
Thomas Werner, Independent Director
Daniel Castillo, Executive Vice President - Lighting
Anne Whitaker, Director

Cree Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Cree a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Cree in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Cree's short interest history, or implied volatility extrapolated from Cree options trading.

Pair Trading with Cree

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Cree position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cree will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to Interpublic Group could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Interpublic Group when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Interpublic Group - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Interpublic Group of to buy it.
The correlation of Interpublic Group is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Interpublic Group moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Interpublic Group moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Interpublic Group can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income.
Note that the Cree Inc information on this page should be used as a complementary analysis to other Cree's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.

Other Consideration for investing in Cree Stock

If you are still planning to invest in Cree Inc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Cree's history and understand the potential risks before investing.
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities